AI diagnostics platform for pathology and precision medicine drug development
Aignostics builds AI models for pathology analysis in drug discovery and clinical trials, with a technically mature stack spanning Python, C++, CUDA, and Kubernetes. The engineering-heavy org (21 of 27 hires) is scaling distributed training infrastructure and data pipelines for medical images, while active pain points around data infrastructure, model transparency, and ISO 13485 compliance reveal the operational friction of moving AI diagnostics into regulated clinical use.
Notable leadership hires: Machine Learning Team Lead
Aignostics develops AI-powered diagnostic tools for pathology, targeting biopharma partners conducting drug discovery, translational research, clinical trials, and companion diagnostic development. The company was spun out from Charité Berlin in 2018 and operates from Berlin and New York. The product stack spans multimodal clinical data ingestion, model training (distributed infrastructure on Kubernetes and GCP/AWS), and API-driven inference for pathology analysis across oncology, immuno-oncology, autoimmune, and neurodegenerative disease research.
Python, C/C++, CUDA, Java, Rust, GitLab, Argo Workflows, GCP, AWS, Kubernetes, React, and Next.js for model training, inference, and platform infrastructure.
Building data infrastructure and distributed training systems for digital pathology, scaling Kubernetes cluster architecture, implementing platform security, developing model training frameworks, and launching public APIs for pathology analysis.
Other companies in the same industry, closest in size